Advertisement

Reply letter to: Peyton CC, Tang D, Reich RR, et al. Downstaging and survival outcomes associated with neoadjuvant chemotherapy regimens among patients treated with cystectomy for muscle-invasive bladder cancer. JAMA Oncol. 2018 Nov 1;4(11):1535–1542

  • Luca BoeriEmail author
  • Emanuele Montanari
  • R. Jeffrey Karnes
Letter to the Editor
  • 28 Downloads

Notes

References

  1. 1.
    Peyton CC, Tang D, Reich RR et al (2018) Downstaging and survival outcomes associated with neoadjuvant chemotherapy regimens among patients treated with cystectomy for muscle-invasive bladder cancer. JAMA Oncol. 4:1535–1542CrossRefGoogle Scholar
  2. 2.
    Boeri L, Soligo M, Frank I et al (2019) Clinical predictors and survival outcome of patients receiving suboptimal neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: a single-center experience. World J Urol. https://doi.org/10.1007/s00345-019-02689-8 (Epub ahead of print)
  3. 3.
    Vetterlein MW, Wankowicz SAM, Seisen T et al (2017) Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology. Cancer 15(123):4346–4355CrossRefGoogle Scholar
  4. 4.
    Boeri L, Soligo M, Frank I et al (2019) Cigarette smoking is associated with adverse pathological response and increased disease recurrence amongst patients with muscle-invasive bladder cancer treated with cisplatin-based neoadjuvant chemotherapy and radical cystectomy: a single-centre experience. BJU Int. https://doi.org/10.1111/bju.14612 (Epub ahead of print)
  5. 5.
    Seiler R, Ashab HAD, Erho N et al (2017) Impact of molecular subtypes in muscle-invasive bladder cancer on predicting response and survival after neoadjuvant chemotherapy. Eur Urol 72:544–554CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • Luca Boeri
    • 1
    Email author
  • Emanuele Montanari
    • 1
  • R. Jeffrey Karnes
    • 2
  1. 1.Department of Urology, Foundation IRCCS Ca’ Granda Ospedale Maggiore PoliclinicoUniversity of MilanMilanItaly
  2. 2.Department of UrologyMayo ClinicRochesterUSA

Personalised recommendations